Camp4 Therapeutics (CAMP) CSO sells $8,272 in common stock

Daniel Tardiff, the Chief Scientific Officer of Camp4 Therapeutics, sold $8,272 worth of common stock. The sale is part of the company's ongoing financial activities but does not indicate any broader corporate changes. Investor awareness of insider trades can impact perceptions of the company's market confidence. Monitoring such transactions might influence decisions for investors considering positions in Camp4 Therapeutics (CAMP).